Iopamiro

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast media presented as a solution for injection for intraarterial and intravenous use. It enhances radiographic visualization of vascular structures and organ outlines during imaging procedures.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iopamiro is an iodinated contrast agent used to improve imaging of vascular and organ structures in several radiographic procedures. - Angiography: improves visualization of arterial and venous anatomy during diagnostic and interventional procedures. - Computed tomography (CT) imaging: provides high‑contrast enhancement of soft tissues and vessels for detailed cross‑sectional images. - Urography: delineates the urinary tract, allowing assessment of kidneys, ureters and bladder. - Cardiac catheterization: enhances coronary and cardiac chamber outlines for functional assessment. - Peripheral vascular imaging: highlights limb arteries and veins to detect stenosis or occlusion.

Iopamiro may cause a range of adverse reactions following injection.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Nausea or mild vomiting. - Transient metallic taste. - Mild headache. - Mild injection‑site pain or bruising. - Temporary increase in serum creatinine.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with respiratory distress. - Acute kidney injury, especially in patients with pre‑existing renal impairment. - Hypotension or cardiovascular collapse. - Seizures or neurologic disturbances. - Severe skin reactions such as Stevens‑Johnson syndrome. - Cardiopulmonary arrest.

When using Iopamiro, clinicians should consider several safety measures. - Renal function assessment: evaluate baseline creatinine and eGFR before administration. - Iodine allergy screening: avoid in patients with known hypersensitivity to iodinated contrast. - Thyroid monitoring: be cautious in patients with hyperthyroidism or thyroid disorders. - Hydration status: ensure adequate hydration to reduce risk of contrast‑induced nephropathy. - Dose minimisation: use the lowest effective volume for the required imaging study. - Store below 25°C: keep in the original container, protect from moisture and light.

Iopamiro can interact with other agents that affect renal function or iodine load.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: may increase total iodine exposure and toxicity. - High‑dose iodine therapy (e.g., amiodarone): can exacerbate iodine overload and thyroid dysfunction. - Nephrotoxic drugs (e.g., aminoglycosides, high‑dose NSAIDs): heighten risk of acute kidney injury.

Moderate Interactions (Monitor Closely): - Diuretics: may alter fluid balance and affect renal clearance of contrast. - Metformin: consider temporary discontinuation in patients with reduced renal function to prevent lactic acidosis. - Beta‑blockers: may mask signs of contrast‑induced hypertension.